Nervous system involvement was common among a cohort of patients with AAV, with these individuals showing less severe renal impairment.

Neuros Medical announced today that the first commercial patient in the U.S. successfully received an FDA-approved Altius ...

In diabetes, much attention goes to sugar control, insulin levels, and the threat of nerve damage. But a new study reveals ...

Viewed this way, “Mind-Body medicine” is the tail wagging the dog, to put it mildly.

The SPRINT PNS System is indicated for up to 60 days for: Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; symptomatic relief of post-traumatic pain; ...

EMJ spoke with Lukas Rasulic to explore the latest advances in peripheral nerve repair, the integration of functional ...

This policy shift moves Nalu from its prior classification of “Investigational/Experimental” to “Medically Necessary” for eligible patients—opening access to more than 22 million additional covered ...

Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.

A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...

JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...

Researchers have observed a mechanism in the brain that may ‘pump the brakes’ on acute pain to prevent overload while not inhibiting chronic pain at all.